Abstract:Original Research Article Metformin hydrochloride (MET) is an oral hypoglycaemic agent which improves glucose tolerance in patients with type 2 diabetes and diminishes basal plasma levels of glucose. The aim of this study was to develop and optimize MET matrix tablets for SR application. The SR matrix tablet of MET was prepared by wet granulation technique using Sodium carboxymethyl cellulose and hydroxyl propyl methylcellulose of different viscosity grades (HPMC K4M, HPMC K15M, and HPMC K100M). The influence of varying the polymer ratios was evaluated. The excipients used in this study did not modify physicochemical properties of the drug. MET has relatively short plasma half-life, low absolute bioavailability. The need for the administration 2 to 3 times a day when larger doses are required can decrease patient fulfilment. SR formulation that would maintain plasma level for 8-12 h might be sufficient for daily dosing of MET. SR products are needed for MET to prolong its duration of action and to improve patient compliances. The developed formulation of tablet (F1 to F6) was evaluated for pre-compression and post–compression method. The results of all parameter were found to be within the limits. The optimized formulations (F6) were subjected to stability studies and shown there were no significant changes in drug content, physicochemical parameters and release pattern. Assay of the pure drug and formulation was carried out by using UV and RP-HPLC method. The in vitro drug dissolution study was carried out using USP apparatus Type I, Basket method and the release mechanisms were explored. Mean dissolution time is used to characterize drug release rate from a dosage form and indicates the drug release is retarding efficiency of the polymer. The in vitro release studies exhibits the release up to 94.8%, over a prolonged period of time which confirms the extended release profile of formulation (F6) after 12 hrs as compared to marketed formulation, invitro drug release data obtained were fitted to various release model excess the possible mechanism of the drug release. In conclusion, development of MET SR tablets is a good approach to sustain the release rate to overcome frequent administration and also to release the drug for prolongs period thus maintaining plasma level above the MEC for desired time period. Further the efficacy of the developed formulations has to be assessed by pharmacokinetic studies in humans. Keyword: Metformin hydrochloride, SR matrix tablet, HPMC K100M, Wet granulation technique, In vitro drug dissolution. Copyright @ 2019: This is an open-access article distributed under the terms of the Creative Commons Attribution license which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use (NonCommercial, or CC-BY-NC) provided the original author and source are credited.

Formulation and evaluation of matrix tablets of Eperisone hydrochloride

Formulation and Evaluation of Extended Release Floating Matrix Tablet of Eperisone Hydrochloride by Direct Compression Method

Study on pramipexole dihydrochloride sustained-release tablets

Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded/spheronized, sintered and compacted pellets

Preparation and Evaluation of Extended Release Trilayered Matrix Tablets of Ramipril Using Design of Experiment

FORMULATION AND EVALUATION OF METFORMIN HYDROCHLORIDE SUSTAINED RELEASE MATRIX TABLETS

Formulation and evaluation of sustained release matrix tablet of captopril

Design and Evaluation of Tramadol HCl Sustained Release Matrix Tablets

Formulation Study and Evaluation of Matrix and Three-layer Tablet Sustained Drug Delivery Systems Based on Carbopols with Isosorbite Mononitrate

In vitro/in vivo evaluation of HPMC/alginate based extended-release matrix tablets of cefpodoxime proxetil

FORMULATION DEVELOPMENT AND EVALUATION OF MATRIX TABLET TRAZODONE HYDROCHLORIDE USING NATURAL POLYMER

A Comprehensive Review on Sustained Release Matrix Drug Delivery System

Formulation Development of Sustained Release Matrix Tablet Containing Metformin Hydrochloride and Study of Various Factors Affecting Dissolution Rate

Formulation and Evaluation of Extended Release Oral Suspension of Metformin Hydrochloride

In- vitro Design and Formulation of Levitiracetam Extended Release Tablets

STATISTICAL DESIGN OF EXPERIMENT-BASED FORMULATION DEVELOPMENT AND OPTIMIZATION OF FLOATING MATRIX TABLET OF ANTI-EMETIC DRUG

Formulation and evaluation of diclofenac controlled release matrix tablets made of HPMC and Poloxamer 188 polymer: An assessment on mechanism of drug release

Formulation and Evaluation of Delayed Release Pellets of Ivabradine Hydrochloride

Evaluation of Carbopol 71G and HPMC As Matrix Materials in a Sustained Release Formulation

NOVEL FORMULATION DESIGN AND IN-VITRO EVALUATION OF EXTENDED RELEASE PELLETS BY COMPLEXATION TECHNIQUE

Stable and Bio-Equivalent Formulation of Alginate Matrix-Based Verapamil Hydrochloride Extended-Release Tablets